Sodium dihydrogen phosphate dihydrate 780mg/5ml oral solution
Requires a prescription from a doctor or prescriber
Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Sodium dihydrogen phosphate dihydrate
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
This is the NHS Drug Tariff indicative price used for reimbursement purposes. It may not reflect the price paid by patients or pharmacies.
View full Drug TariffSource: NHS Drug Tariff via NHSBSA. Derived from dm+d VMPP (Virtual Medicinal Product Pack) pricing data. Contains public sector information licensed under the Open Government Licence v3.0.
WHO defined daily dose (DDD)
50 gram
Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.
Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via NHS dm+d BNF mapping files. Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Clinical guidelines and formulary information
British National Formulary
Sodium dihydrogen phosphate dihydrate
Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & product information
Official product databases and supply status monitoring
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
44 found
Half-life
Not available
Mechanism
Sodium phosphate is thought to work by increasing the amount of solute present i…
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
1-3h
[A19448]
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 781 interactions
[L799]
Phosphate toxicity is likely due to the disturbance of other electrolytes when phosphate levels are high, producing symptoms including tetany, dehydration, hypotension, tachycardia, hyperpyrexia, cardiac arrest and coma .
[A19449]
Risk of raising phosphate levels through use of sodium phosphate appears to be higher in smaller patients .
[A19448]
How the body processes this drug — absorption, distribution, metabolism, and elimination
[A19448]
Proteins that transport this drug across cell membranes
PMID:11009570 PMID:16790504 PMID:17494632 PMID:19726692 PMID:7929240 PMID:8041748
May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification .
PMID:11009570
Essential for cell proliferation but this function is independent of its phosphate transporter activity PMID:19726692
PMID:12205090 PMID:15955065 PMID:16790504 PMID:17494632 PMID:22327515 PMID:28722801 PMID:30704756
Plays a critical role in the determination of bone quality and strength by providing phosphate for bone mineralization (By similarity). Required to maintain normal cerebrospinal fluid phosphate levels (By similarity). Mediates phosphate-induced calcification of vascular smooth muscle cells (VCMCs) and can functionally compensate for loss of SLC20A1 in VCMCs (By similarity)
PMID:12324554 PMID:20335586 PMID:26047794 PMID:8327470
The cotransport has a Na(+):Pi stoichiometry of 3:1 and is electrogenic (By similarity)
PMID:11880379
The cotransport has a Na(+):Pi stoichiometry of 2:1 and is electroneutral (By similarity)
ATC A06AG01
ATC V03AG05
ATC A06AD17
ATC B05XA09
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Sodium phosphate, monobasic
Matched from: Sodium dihydrogen phosphate dihydrate
Additional database identifiers
Drugs Product Database (DPD)
293
Drugs Product Database (DPD)
4753
Drugs Product Database (DPD)
4759
Drugs Product Database (DPD)
20445
ChemSpider
22626
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10946
GeneCards
SLC20A1
UniProt Accession
S20A1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10947
GeneCards
SLC20A2
UniProt Accession
S20A2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11019
GeneCards
SLC34A1
UniProt Accession
NPT2A_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11020
GeneCards
SLC34A2
Guide to Pharmacology
1136
UniProt Accession
NPT2B_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:20305
GeneCards
SLC34A3
UniProt Accession
NPT2C_HUMAN
Patent information
1 active patent, 1 expired
Source: DrugBank · CC BY-NC 4.0. Patent data sourced from national patent offices. Expiry dates may not reflect extensions, regulatory exclusivity periods, or legal challenges.
DrugBank citations
If you use DrugBank data in your research, please cite the following publications: